Clinical Trial Update: Assessment of the Initial Efficacy and Safety of BRM424 Ophthalmic Solutions in Patients With Neurotrophic Keratitis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating the initial efficacy and safety of BRM424 ophthalmic solution in neurotrophic keratitis; the study status is recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neurotrophic Keratitis

Drugs mentioned

• BRM424

Snippet

Sponsor: BRIM Biotechnology Inc. | Conditions: Neurotrophic Keratitis | Phase 2 | Status: RECRUITING